(Q53615353)

16 May 2018

title

The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects. (English)

1 reference

16 May 2018

author

Wiek H van Gilst

7

1 reference

16 May 2018

author name string

Megan V Cannon

1

1 reference

16 May 2018

Hongjuan Yu

2

1 reference

16 May 2018

Wellington M Candido

3

1 reference

16 May 2018

Martin M Dokter

4

1 reference

16 May 2018

Eva-Lotte Lindstedt

5

1 reference

16 May 2018

Herman H W Silljé

6

1 reference

16 May 2018

Rudolf A de Boer

8

1 reference

16 May 2018

publication date

11 February 2015

1 reference

16 May 2018

European Journal of Heart Failure

published in

1 reference

16 May 2018

volume

17

1 reference

16 May 2018

issue

3

1 reference

16 May 2018

page(s)

273-282

1 reference

16 May 2018

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

cites work

1 reference

Cardiac hypertrophy: the good, the bad, and the ugly

21 January 2018

1 reference

Identification and characterization of two alternatively spliced transcript variants of human liver X receptor alpha

21 January 2018

1 reference

Liver x receptor signaling pathways and atherosclerosis

21 January 2018

1 reference

Liver X receptors as integrators of metabolic and inflammatory signaling

21 January 2018

1 reference

Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivo

21 January 2018

1 reference

Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta

21 January 2018

1 reference

Liver X receptors alpha and beta regulate renin expression in vivo

21 January 2018

1 reference

Activation of liver X receptor-alpha reduces activation of the renal and cardiac renin-angiotensin-aldosterone system

21 January 2018

1 reference

GW3965, a synthetic liver X receptor (LXR) agonist, reduces angiotensin II-mediated pressor responses in Sprague-Dawley rats

21 January 2018

1 reference

Liver X receptor modulators: a review of recently patented compounds (2009 - 2012).

21 January 2018

1 reference

Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels.

21 January 2018

1 reference

Liver X Receptor Signaling Pathways in Cardiovascular Disease

21 January 2018

1 reference

Liver X receptors are negative regulators of cardiac hypertrophy via suppressing NF-kappaB signalling

21 January 2018

1 reference

Transforming growth factor (TGF)-β signaling in cardiac remodeling.

21 January 2018

1 reference

RAP250 is a coactivator in the transforming growth factor beta signaling pathway that interacts with Smad2 and Smad3.

21 January 2018

1 reference

Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy

21 January 2018

1 reference

A liver-X-receptor ligand, T0901317, attenuates IgE production and airway remodeling in chronic asthma model of mice

21 January 2018

1 reference

Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis.

21 January 2018

1 reference

Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes

21 January 2018

1 reference

Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.

21 January 2018

1 reference

The LXRs: a new class of oxysterol receptors

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Role of myocytes in myocardial collagen production

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/EJHF.243

1 reference

16 May 2018

1 reference

16 May 2018